Tokyo-based ASKA Pharmaceutical Co announced that it has completed negotiations to acquire a 24.9 per cent stake in the Vietnamese pharmaceutical company Ha Tay Pharmaceutical JSC (Hataphar).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
